FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, and may be used for detection of malignant tumours, including breast cancer, kidney cancer. That is ensured by measuring the expression of a polypeptide binding by an antigen-antibody reaction to CAPRIN-1 protein having any of even-numbered amino acid sequences SEQ ID NO:2-30 of the list of sequences in a sample taken from a living body, by the antigen-antibody reaction in the sample taken from the living body. What is also presented is an agent for detection of a malignant tumour.
EFFECT: group of inventions provides higher sensitivity of diagnosing malignant tumours.
18 cl, 4 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETECTING MALIGNANT TUMOURS | 2014 |
|
RU2671497C2 |
METHOD FOR PANCREATIC CANCER DETECTION | 2012 |
|
RU2624040C2 |
METHOD FOR CANCER DETECTION | 2013 |
|
RU2646466C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2603742C2 |
METHOD FOR CANCER DETECTION | 2013 |
|
RU2646464C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING MALIGNANT GROWTHS | 2009 |
|
RU2498819C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2595400C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2610428C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2641260C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2012 |
|
RU2611197C2 |
Authors
Dates
2014-06-10—Published
2009-08-05—Filed